Vice President JD Vance referred hospitals and healthcare providers to the Department of Justice for alleged fraud tied to gender transition treatments on minors, warning that those who intentionally miscoded billing should face prison time.
Vance announced the move Thursday alongside HHS Secretary Robert F. Kennedy Jr. and Assistant HHS Secretary Brian Christine in a video posted to X. In a separate letter to Attorney General Todd Blanche, Vance formally referred a new HHS report and the allegations it contains, asking DOJ to determine whether the identified providers violated federal law, regulations, or policies.
The referral centers on an HHS report titled "Wolves in White Coats," which outlines practices at hospitals that prescribed experimental gender treatments to children with limited supporting evidence. The report found more than 225 hospitals and health systems had established pediatric gender programs nationwide.
The HHS findings put a dollar figure on the alleged misconduct. The report identified roughly $61 million in potentially fraudulent Medicaid claims for puberty blockers billed under misleading diagnostic codes for patients aged 9 to 17 between 2015 and 2025. About $50 million of those claims used a general "endocrine disorder, unspecified" billing code, a vague classification that obscured the actual purpose of the treatment. Another $11 million was billed under a "precocious puberty" diagnosis for patients aged 13 to 17, an age range for which that diagnosis does not medically apply.
The billing pattern described in the report amounts to a straightforward allegation: providers used inaccurate codes to get insurers, including taxpayer-funded Medicaid, to pay for treatments those insurers would not have covered under the correct coding. That is the textbook definition of healthcare fraud.
Vance, who leads the White House anti-fraud task force, has made rooting out fraudulent billing a recurring priority. His earlier work targeting fraud in migrant communities signaled a willingness to pursue cases that previous administrations left untouched.
The vice president's letter to Blanche did not hold back about why the referral matters. Vance wrote:
"Unfortunately, children who express discomfort with their sex have come to be viewed as profit centers by some hospitals and doctors."
That framing, children as revenue sources, sits at the core of the administration's case. Gender transition treatments can cost up to $75,000 without surgery and nearly $170,000 with surgery, Fox News reported, compared to an average healthcare cost of roughly $3,000 for a typical minor. The financial incentive to steer young patients toward these treatments is not subtle.
In the same letter, Vance drew a clear line between accountability and criminal liability. He wrote that providers who miscoded treatments "should be held accountable," and added:
"If they have done so intentionally, thereby perpetrating a fraud on Medicaid or on private insurers, they should go to prison."
Vance also stated in the announcement that the administration would not stand by while these practices continued. He said hospitals that convinced "vulnerable children to reject their gender" could create "patients for life, earning hospitals tens of thousands of dollars in additional revenue per child."
The vice president has faced a turbulent stretch in Washington. Reports of growing isolation inside the West Wing have trailed him in recent weeks, but the fraud referral positions Vance on firm ground with the conservative base, protecting children and defending taxpayer dollars from institutional abuse.
The scale documented in the HHS report is worth pausing on. More than 225 hospitals and health systems built out dedicated pediatric gender programs across the country. These were not fringe clinics. They were established medical institutions that created entire departments around a treatment model now under federal scrutiny for potential fraud.
The report's title, "Wolves in White Coats", captures the administration's view of what happened. Providers who were supposed to act in children's best medical interest instead, according to the HHS findings, billed for treatments under codes designed to hide the true nature of the care from insurers.
Vance urged the DOJ to send a message. He wrote that rather than allowing "the proliferation of harmful, sex-rejecting procedures on our children, we must send a clear message that any hospitals and providers that have participated in these practices will face justice."
The referral now sits with Attorney General Blanche. The DOJ has not publicly responded to or acknowledged receipt of the letter. No specific providers have been publicly named, and no charges have been filed. The referral asks DOJ to make that determination, whether the conduct documented by HHS crosses the line from aggressive billing into criminal fraud.
Several open questions remain. The full scope of the "Wolves in White Coats" report has not been made public in detail. It is unclear whether the referral covers only providers treating minors or extends to adult patients as well. The specific federal statutes the administration believes were violated have not been identified in the letter or the public announcement. And the identities of the hospitals and providers flagged in the report remain undisclosed.
Vance's office has undergone staff changes in recent months, but the vice president has kept his public focus on the anti-fraud portfolio. This referral is the most aggressive step yet in that effort, moving from identifying problems to demanding criminal consequences.
The joint appearance with Kennedy and Brian Christine was deliberate. HHS produced the report. The vice president's office made the referral. And the DOJ is now expected to act on it. The three officials appearing together on video signaled that the administration's health and law-enforcement arms are aligned on the issue.
Kennedy, who has made the safety and integrity of medical treatments a central theme of his tenure at HHS, has not issued a separate public statement on the referral. Christine's precise role in the referral process beyond appearing in the announcement video has not been detailed.
For years, critics of pediatric gender medicine argued that the financial incentives in the system were warping clinical judgment. The HHS report now gives that argument a federal imprimatur, and $61 million in documented billing to back it up. Whether DOJ pursues criminal cases will determine if the referral carries real consequences or remains a political statement.
Vance has positioned himself as a combative public figure willing to pick fights that other politicians avoid. This one puts him squarely between parents who want answers and an industry that built a multimillion-dollar billing apparatus around children who needed help, not a revenue model.
When hospitals turn confused kids into profit centers and bill taxpayers for the privilege, the question is not whether someone should be held accountable. It is why it took this long.